The tumor progression rates did not exhibit a substantial difference between the um and ck groups; however, tumor volume and weight were significantly reduced, and the survival time of the mice was notably improved following treatment with anti-PD-1/PD-L1 alone or in combination with USMC. Here, PDCD1 is linked to neoplasm.